Hürthle cell neoplasms of the thyroid gland: reassessment of functional capacity.
We treated a hyperthyroid man and a euthyroid woman who had autonomously functioning Hürthle cell adenomas and demonstrated uptake of radioactive 131I in a woman with recurrent Hürthle cell carcinoma. Since these tumors are thought to be inactive, we reassessed the functional capacity of Hürthle cell neoplasms by reviewing the medical records of all patients operated upon for these tumors at our medical center from 1950 through November, 1993. We also reviewed series of Hürthle cell neoplasms identified from a MEDLINE search of papers published from 1960 to November, 1993. We identified 92 patients with Hürthle cell neoplasms. Thyroid scintigraphy was performed in 28 of 72 patients with benign adenomas and six of 20 patients with Hürthle cell carcinomas. In addition to the two index cases, four euthyroid patients had hot nodules that partially suppressed the extranodular tissue; seven patients had warm nodules. Thyroid scans performed in patients with Hürthle cell carcinomas revealed five cold nodules and one warm nodule. Our index patient with carcinoma displayed elevated serum thyroglobulin levels when the cancer recurred. This patient and another had uptake of 131I by recurrent or metastatic cancer that allowed for treatment with this nuclide. Of 539 patients identified in a literature survey, 489 had benign Hürthle cell adenomas and 50 had Hürthle cell carcinoma. Thyroid scans performed in 282 patients revealed 247 cold nodules, 20 warm nodules, and 8 hot nodules. Our results, added to those published in case series of Hürthle cell neoplasms, indicated that 4.4% of thyroid scans were hot and 8.9% were warm.(ABSTRACT TRUNCATED AT 250 WORDS)
Section of Endocrinology, Gundersen/Lutheran Medical Center, La Crosse, Wisconsin 54601.
R H
RH
Caplan
R M
RM
Abellera
W A
WA
Kisken
D000230:Adenocarcinoma / Q000473:pathology / Q000503:physiopathology* / Q000532:radiotherapy; D018249:Adenoma, Oxyphilic / Q000473:pathology / Q000503:physiopathology* / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013954:Thyroglobulin / Q000097:blood; D013960:Thyroid Function Tests; D013964:Thyroid Neoplasms / Q000473:pathology / Q000503:physiopathology* / Q000532:radiotherapy; D013971:Thyrotoxicosis / Q000209:etiology / Q000473:pathology; D013974:Thyroxine / Q000097:blood
D007457:Iodine Radioisotopes; D013954:Thyroglobulin; D013974:Thyroxine